dapsone has been researched along with Infection, Mycobacterium avium-intracellulare in 9 studies
Excerpt | Relevance | Reference |
---|---|---|
"carinii prophylaxis before the onset of AIDS: Mycobacterium avium complex disease, which developed in 33." | 1.29 | Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. ( Anderson, R; Bacellar, H; Detels, R; Hoover, DR; Kaslow, RA; Phair, J; Saah, AJ, 1993) |
" Pyrimethamine in combination with a fixed concentration of dapsone at 0." | 1.29 | Enhanced in vitro activity of pyrimethamine in combination with dapsone against Mycobacterium avium complex. ( Cynamon, MH; Meyer, SC; Shah, LM, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 8 (88.89) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Opravil, M | 1 |
Pechère, M | 1 |
Lazzarin, A | 1 |
Heald, A | 1 |
Rüttimann, S | 1 |
Iten, A | 1 |
Furrer, H | 1 |
Oertle, D | 1 |
Praz, G | 1 |
Vuitton, DA | 1 |
Cabié, A | 1 |
Matheron, S | 1 |
Khuong, MA | 1 |
Bouchaud, O | 1 |
Saimot, AG | 1 |
Coulaud, JP | 1 |
Hoover, DR | 1 |
Saah, AJ | 1 |
Bacellar, H | 1 |
Phair, J | 1 |
Detels, R | 1 |
Anderson, R | 1 |
Kaslow, RA | 1 |
Shah, LM | 1 |
Meyer, SC | 1 |
Cynamon, MH | 1 |
Sackoff, J | 1 |
McFarland, J | 1 |
Su, S | 1 |
Bryan, E | 1 |
Cheng, B | 1 |
Hardy, WD | 1 |
Gonzalez, AH | 1 |
Berlin, OG | 1 |
Bruckner, DA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for dapsone and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
3 trials available for dapsone and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Topics: Adult; CD4 Lymphocyte Count; Dapsone; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Huma | 1995 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agent | 1998 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
6 other studies available for dapsone and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Dapsone as prophylaxis for disseminated Mycobacterium avium complex infection.
Topics: Dapsone; Humans; Mycobacterium avium-intracellulare Infection; Pentamidine; Retrospective Studies; T | 1995 |
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Candidiasis; CD4-Positive | 1993 |
Enhanced in vitro activity of pyrimethamine in combination with dapsone against Mycobacterium avium complex.
Topics: Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Synergism; Humans; Microbial Sensitivity Tes | 1996 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |
In-vitro activity of dapsone and two potentiators against Mycobacterium avium complex.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Synergism; Humans; Microbia | 1989 |